2014 Marks Another Record-Breaking Year for the Shady Grove Fertility IVF Program
Rockville, MD (PRWEB) July 29, 2015 -- Shady Grove Fertility has published its 23rd Annual IVF Program Report, a yearly compendium of treatment outcomes. In 2014, Shady Grove Fertility performed more in vitro fertilization (IVF) cycles than any other year in the practice’s history. Shady Grove Fertility’s 32 reproductive endocrinologists performed over 5,000 fresh IVF cycles, leading to over 3,000 babies being conceived and 8 babies born every day.
Contributing to these record-breaking numbers was the growing use of frozen embryos, which increased the likelihood of pregnancy for patients. Patients who use frozen embryos now experience success rates equal to—or sometimes greater than—fresh embryo transfer cycles. In addition to these success rates, frozen embryos provide patients with many advantages, such as the ability to have more chances for conception if a cycle is unsuccessful, or an opportunity if patients want to grow their family in the future. Further, frozen cycles are less costly and less physically demanding than fresh cycles, and allow for embryo genetic testing.
In 2014, elective single embryo transfer (eSET) also continued to gain prominence as patients became more educated regarding the risk of multiples. In good prognosis patients, Shady Grove Fertility strongly advocates for patients to transfer one embryo. As a result, the practice has drastically reduced the number of multiple pregnancies, making pregnancy safer without a significant effect on pregnancy success rates. In 2014, approximately 83 percent of all pregnant patients in the IVF Program had a singleton pregnancy, leading to the twin rate falling from 20 percent to 16 percent and the triplet rate remaining at less than 1 percent.
Across all segments of the IVF Program in 2014, maternal age continued to be the dominant factor in a woman’s ability to conceive using her own eggs. While it is commonly known that female fertility declines with age, the effectiveness of fertility treatment also follows a similar pattern. While treatments are available for patients whose age is a factor, early intervention is key. Shady Grove Fertility’s patient education has been widespread in this area, and has also grown to include a consideration of the patient’s age when she has her last child.
“2014 represented another year in which our physicians, research team, and staff worked to advance available laboratory technologies to provide our patients with the best possible care and greatest chances of conception. We are grateful to have helped so many individuals build their families and are proud to have had over 3,000 babies conceived through our IVF Program in 2014,” said Michael J. Levy, M.D., President and Director of IVF at Shady Grove Fertility.
About Shady Grove Fertility
Shady Grove Fertility is a leading fertility and IVF center of excellence offering patients individualized care, innovative financial options, and pregnancy rates among the highest in the nation. Since 1991, more than 37,000 babies have been born to patients from all 50 states and over 35 countries around the world. Shady Grove Fertility physicians actively train residents and reproductive endocrine fellows and invest in continuous clinical research and education to advance the field of reproductive medicine through numerous academic appointments and partnerships with Georgetown Medical School, the University of Maryland, Walter Reed, and the National Institutes of Health. Today, 32 reproductive endocrinologists, PhD scientists, geneticists, and more than 600 highly specialized Shady Grove Fertility staff care for patients in 18 full-service offices, and four satellite sites throughout Pennsylvania, Maryland, Virginia, and Washington, D.C. For more information, call 1-888-761-1967 or visit http://www.ShadyGroveFertility.com.
Courtney Cohen, Shady Grove Fertility, http://www.shadygrovefertility.com, +1 (202) 997-4515, [email protected]
Share this article